Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid A Mayer

Showing results (1-10 of 147) with videos related to

Pageof 15
Sort By:
Clinical Breast Cancer|July 15, 2009
Treatment of HER2-positive metastatic breast cancer following initial progressionIngrid A Mayer
Journal of the National Comprehensive Cancer Network : JNCCN|May 22, 2015
Advanced hormone-sensitive breast cancer: overcoming resistanceIngrid A Mayer
Cancer Treatment and Research|October 8, 2005
Targeting cytokine receptors and pathways in the treatment of breast cancerIngrid A Mayer
Clinical Advances in Hematology & Oncology : H&O|June 5, 2014
Subtyping of triple-negative breast cancerIngrid A Mayer
Current Breast Cancer Reports|February 17, 2016
Clinical Implications of Mutations in the PI3K Pathway in HER2+ Breast Cancer: Prognostic or Predictive?Ingrid A Mayer
Clinical Breast Cancer|July 1, 2010
Antiangiogenic therapies in early-stage breast cancerChristina Derleth, Ingrid A Mayer
Current Oncology Reports|May 27, 2015
Optimizing the use of neoadjuvant endocrine therapyLaila S Agrawal, Ingrid A Mayer
Current Breast Cancer Reports|November 25, 2014
Molecular Heterogeneity of Triple Negative Breast CancerVandana G Abramson, Ingrid A Mayer
Clinical Advances in Hematology & Oncology : H&O|February 7, 2015
Platinum agents in the treatment of early-stage triple-negative breast cancer: is it time to change practice?Laila Saied Agrawal, Ingrid A Mayer
Clinical Advances in Hematology & Oncology : H&O|August 19, 2021
New targets in endocrine-resistant hormone receptor-positive breast cancerLaura C Kennedy, Ingrid A Mayer
Pageof 15

Showing results (1-10 of 147) with videos related to

Sort By:
Pageof 15
Clinical Breast Cancer|July 15, 2009
Treatment of HER2-positive metastatic breast cancer following initial progressionIngrid A Mayer
Journal of the National Comprehensive Cancer Network : JNCCN|May 22, 2015
Advanced hormone-sensitive breast cancer: overcoming resistanceIngrid A Mayer
Cancer Treatment and Research|October 8, 2005
Targeting cytokine receptors and pathways in the treatment of breast cancerIngrid A Mayer
Clinical Advances in Hematology & Oncology : H&O|June 5, 2014
Subtyping of triple-negative breast cancerIngrid A Mayer
Current Breast Cancer Reports|February 17, 2016
Clinical Implications of Mutations in the PI3K Pathway in HER2+ Breast Cancer: Prognostic or Predictive?Ingrid A Mayer
Clinical Breast Cancer|July 1, 2010
Antiangiogenic therapies in early-stage breast cancerChristina Derleth, Ingrid A Mayer
Current Oncology Reports|May 27, 2015
Optimizing the use of neoadjuvant endocrine therapyLaila S Agrawal, Ingrid A Mayer
Current Breast Cancer Reports|November 25, 2014
Molecular Heterogeneity of Triple Negative Breast CancerVandana G Abramson, Ingrid A Mayer
Clinical Advances in Hematology & Oncology : H&O|February 7, 2015
Platinum agents in the treatment of early-stage triple-negative breast cancer: is it time to change practice?Laila Saied Agrawal, Ingrid A Mayer
Clinical Advances in Hematology & Oncology : H&O|August 19, 2021
New targets in endocrine-resistant hormone receptor-positive breast cancerLaura C Kennedy, Ingrid A Mayer
Pageof 15